Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

Novartis Chief Eyes Ways To End Higher US Drug Prices: Media

Novartis already announced in April that it plans to invest $23 billion in the United States over five years (Credit: AFP)

Amid a threat of towering US tariffs, Swiss pharmaceutical giant Novartis is seeking ways to enable Americans to pay less for their medicines, its chief said in an interview published Saturday.

Vasant Narasimhan told the Swiss daily Neue Zurcher Zeitung (NZZ) that his company was "working to eliminate the price gap between the US and other industrialised countries".

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.